- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of Glycemic Variability in Diabetes Mellitus
Authors
Keywords
-
Journal
INTERNAL MEDICINE
Volume 61, Issue 3, Pages 281-290
Publisher
Japanese Society of Internal Medicine
Online
2021-09-18
DOI
10.2169/internalmedicine.8424-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
- (2021) Bao Sun et al. Cardiovascular Diabetology
- Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
- (2021) Satomi Wakasugi et al. Cardiovascular Diabetology
- Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study
- (2021) Yuri D. Foreman et al. DIABETOLOGIA
- Glycemic variability and cardiovascular disease in patients with type 2 diabetes
- (2021) Marcela Martinez et al. BMJ Open Diabetes Research & Care
- Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
- (2021) Satomi Wakasugi et al. BMJ Open Diabetes Research & Care
- Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
- (2020) Ayako Fuchigami et al. Cardiovascular Diabetology
- Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
- (2020) Chun-Pai Yang et al. Cardiovascular Diabetology
- Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
- (2020) Chang-Sheng Sheng et al. DIABETES CARE
- Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
- (2020) Jee Hee Yoo et al. Diabetes Technology & Therapeutics
- Ultra Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Sub-Study
- (2020) Maciej Tadeusz Malecki et al. Diabetes Technology & Therapeutics
- Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials
- (2020) Thomas Danne et al. DIABETES OBESITY & METABOLISM
- Effects of Insulin Degludec and Insulin Glargine U300 on Glycemic Stability in Individuals with Type 1 Diabetes: a Multicenter, Randomized Controlled Crossover Study
- (2020) Hiroshi Miura et al. DIABETES OBESITY & METABOLISM
- Glycemic variability – the danger of a physiologically stable metric
- (2020) Tadej Battelino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study
- (2020) Norihiro Kuroda et al. Journal of Diabetes Investigation
- Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study
- (2020) Da Young Lee et al. Cardiovascular Diabetology
- Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
- (2020) Jingyi Lu et al. DIABETES CARE
- Association of time in range with hemoglobin A1c, glycated albumin, and 1,5‐anhydro‐D‐glucitol
- (2020) Mana Ohigashi et al. Journal of Diabetes Investigation
- Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
- (2020) Junpeng Yang et al. Journal of Diabetes Investigation
- Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
- (2020) Stefan D. Anker et al. CIRCULATION
- Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome
- (2019) Edouard Gerbaud et al. DIABETES CARE
- Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
- (2019) Chantal Mathieu et al. DIABETES CARE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Pilot Study of the Effect of Trelagliptin and Alogliptin on Glycemic Variability in Patients with Type 2 Diabetes
- (2019) Rimei Nishimura et al. ADVANCES IN THERAPY
- Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study
- (2019) Jan Šoupal et al. DIABETES CARE
- Time in range is associated with carotid intima-media thickness in type 2 diabetes
- (2019) Jingyi Lu et al. Diabetes Technology & Therapeutics
- Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes
- (2019) Sheyu Li et al. DIABETES CARE
- The application of simple metrics in the assessment of glycaemic variability
- (2018) L. Monnier et al. DIABETES & METABOLISM
- Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials
- (2018) Tomohide Yamada et al. DIABETES OBESITY & METABOLISM
- A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes
- (2018) Andre Gustavo Daher Vianna et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes
- (2018) Suresh Rama Chandran et al. Diabetes Technology & Therapeutics
- Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus
- (2018) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
- (2018) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
- (2018) Lutz Heinemann et al. LANCET
- Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
- (2018) Jin J. Zhou et al. DIABETES CARE
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- The impact of food order on postprandial glycaemic excursions in prediabetes
- (2018) Alpana P. Shukla et al. DIABETES OBESITY & METABOLISM
- Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial
- (2018) Robert R. Henry et al. Diabetes Technology & Therapeutics
- Glycaemic variability in diabetes: clinical and therapeutic implications
- (2018) Antonio Ceriello et al. Lancet Diabetes & Endocrinology
- Effectiveness of insulin glargine U-300 versus insulin glargine U-100 on nocturnal hypoglycemia and glycemic control in type 1 and type 2 diabetes: a systematic review and meta-analysis
- (2018) Ana Díez-Fernández et al. ACTA DIABETOLOGICA
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
- (2018) Jingyi Lu et al. Journal of Diabetes Investigation
- Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis
- (2018) Qian Zhao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients
- (2017) Jee-Eun Yoon et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM
- (2017) Chun-Pai Yang et al. NEUROLOGY
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Visit‐to‐Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All‐Cause Mortality in the General Population
- (2017) Anxin Wang et al. Journal of the American Heart Association
- The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes
- (2016) Helena W. Rodbard et al. DIABETES CARE
- Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
- (2016) Louis Monnier et al. DIABETES CARE
- New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
- (2016) M. Matsuhisa et al. DIABETES OBESITY & METABOLISM
- Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy
- (2016) Johan Jendle et al. DIABETES OBESITY & METABOLISM
- The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial
- (2016) Kristian Karstoft et al. DIABETOLOGIA
- Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study
- (2015) Tsung-Yuan Yang et al. ACTA DIABETOLOGICA
- Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study
- (2015) Rimei Nishimura et al. Cardiovascular Diabetology
- Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
- (2015) Catherine Gorst et al. DIABETES CARE
- Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring
- (2015) Yoshiki Kusunoki et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
- (2015) S. Heller et al. DIABETIC MEDICINE
- Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes
- (2015) Ya-Fei Yang et al. MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes
- (2014) Antonio Ceriello et al. DIABETES CARE
- Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
- (2014) Yoichiro Hirakawa et al. DIABETES CARE
- New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1
- (2014) R. H. A. Becker et al. DIABETES CARE
- Glycemic Variability Is Higher in Type 1 Diabetes Patients with Microvascular Complications Irrespective of Glycemic Control
- (2014) Jan Šoupal et al. Diabetes Technology & Therapeutics
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- HbA1c Variability as an Independent Risk Factor for Diabetic Retinopathy in Type 1 Diabetes: A German/Austrian Multicenter Analysis on 35,891 Patients
- (2014) Julia M. Hermann et al. PLoS One
- HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
- (2013) G. Penno et al. DIABETES CARE
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin
- (2013) Hun-Sung Kim et al. Diabetes Technology & Therapeutics
- HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes
- (2013) K. Hietala et al. DIABETOLOGIA
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
- (2013) Yoshiki Kusunoki et al. Diabetes Therapy
- Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
- (2012) R. E. Ratner et al. DIABETES OBESITY & METABOLISM
- Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Does Glycemic Variability Impact Mood and Quality of Life?
- (2012) Sue Penckofer et al. Diabetes Technology & Therapeutics
- Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data
- (2012) Yongming Qu et al. Diabetes Technology & Therapeutics
- HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study
- (2012) C. C. Hsu et al. DIABETOLOGIA
- Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
- (2012) Yoshiki Kusunoki et al. ENDOCRINE JOURNAL
- Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress
- (2011) Jingli Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
- (2011) Muhammad A. Abdul-Ghani et al. ENDOCRINE REVIEWS
- Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
- (2010) Hisko Oeseburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals
- (2010) N. Gogitidze Joy et al. DIABETES CARE
- Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation: Putative mechanism for aggravating vascular disease in diabetes
- (2010) R. J. Wright et al. DIABETES CARE
- Hypoglycemia, Diabetes, and Cardiovascular Events
- (2010) C. V. Desouza et al. DIABETES CARE
- Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
- (2010) P. Anagnostis et al. DIABETES OBESITY & METABOLISM
- Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes
- (2009) E. S. Kilpatrick et al. DIABETES CARE
- Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control
- (2009) David Rodbard Diabetes Technology & Therapeutics
- Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT
- (2009) S. E. Siegelaar et al. DIABETOLOGIA
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
- (2009) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients
- (2008) A. Ceriello et al. DIABETES
- A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
- (2008) E. S. Kilpatrick et al. DIABETES CARE
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
- (2008) J. S. Skyler et al. DIABETES CARE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now